Back

Peripheral artery disease risk prediction in patients with severe aortic valve stenosis

1 September 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Risk of peripheral artery disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Martin Steinmetz

University clinic Knappschafts Hospital, Bochum (Germany)

6 More presentations in this session

Presentation thumbnail
Fine particulate matter exposure and the risk of peripheral revascularization: a post-hoc AIRCARD analysis
Doctor S. Mayntz (Odense, DK)
Abstract Slides Video
Presentation thumbnail
Impact of the below-knee lower extremity arterial calcification score on clinical outcomes in patients with intermittent claudication due to iliofemoral artery disease
Doctor K. Kawamura (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Longitudinal change in ankle-brachial index and incident cardiovascular disease and all-cause mortality
Doctor J. Song (Qingdao, CN)
Abstract Slides Video
Presentation thumbnail
Categorization of patients with peripheral artery disease by charlson comorbidity index
Doctor M. Meertens (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Differences between female and male sarcopenic patients with peripheral artery disease
Doctor V. Schmitt (Mainz, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk of peripheral artery disease

The Event

Event poster

ESC Congress 2025

1 September 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparative analysis of a novel preoperative stratification method versus traditional scores in patients with severe aortic stenosis undergoing aortic valve surgery
thumbnail
Congress Presentation
ASGARD risk scores for long-term, individualized cardiovascular surveillance of low-risk patients with asymptomatic non-severe aortic valve stenosis: development and internal validation
thumbnail
Congress Session
Predictors of TAVI outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources